KYMR

Kymera Therapeutics
KYMR

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.99B
EV
$1.23B
Shares Outstanding
80.10M
Beta
2.23

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$57.67
P/E 2025E
-
P/Revenue 2025E
33.17x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Kymera Therapeutics, Inc.

gainify
KYMR

Kymera Therapeutics, Inc.

KYMR

Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. It engages in developing ...

Sector

Healthcare

Industry

Biotechnology

CEO

Mainolfi, Nello

Employees

188

IPO Date

2020-08-21

Headquarters

200 Arsenal Yards Boulevard, Suite 230, Watertown, Massachusetts, 02472, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved